Efficacy and Safety of a Single Tearmaestro <sup>®</sup> Liquid Pulsation Treatment for Meibomian Gland Dysfunction-Related Dry Eye Disease: A Prospective Study
A single Tearmaestro<sup>®</sup> liquid pulsation treatment significantly improves the primary outcome of patient-reported symptoms at 1 month, with concurrent benefits in tear film stability and meibomian gland function lasting up to 3 months. The treatment demonstrated a favorable safety profile, offering an efficient clinical option for MGD-related dry eye.
Authors
- Yiyun Yue (ORCID: https://orcid.org/0000-0002-8620-7509)
- Zhenying Shang
- Huan Liu (ORCID: https://orcid.org/0000-0002-0253-647X)
- Yue Huang (ORCID: https://orcid.org/0009-0000-6431-6512)
- Ruibo Yang
- Fei Li
- Shaozhen Zhao
- Chen Zhang
- Yan Xu
- Jing Yan
- Qiwei Li
Institutions
- Tianjin Medical University Eye Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Current Eye Research
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1080/02713683.2026.2642152
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00